drugset / Trial / NCT03542838
Study of Resiniferatoxin for Knee Pain in Moderate to Severe Osteoarthritis
RandomizedParallel-groupDouble-blindTreatment
Summary
This study evaluates the safety of resiniferatoxin in patients with moderate to severe knee pain due to osteoarthritis.
Timeline
- Start
- 2018-07-12
- Primary completion
- 2020-04-13
- Completion
- 2021-02-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Resiniferatoxin | Other / unclassified | 5 ug | Other |
| Subject | Resiniferatoxin | Other / unclassified | 12.5 ug | Other |
| Subject | Resiniferatoxin | Other / unclassified | 20 ug | Other |
| Subject | Resiniferatoxin | Other / unclassified | 25 ug | Other |
| Subject | Resiniferatoxin | Other / unclassified | 30 ug | Other |